Tenderwize
Back to tender search

Posaconazole drug discount agreements

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 131 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Posaconazol, ATC J02AC04

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

46 / 100

Complexity

62 / 100

Risk factors

No estimated value, expected demand, volumes, or other financial parameters are provided in the available notice.

The buyer may introduce exclusive rebate contracts during the term, causing the open-house contract to end automaticall...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Mar 31, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive pharmaceutical rebate agreements under §§130a(8) and 130c(1) SGB V for Posaconazole, ATC J02AC04.
  • Supply of authorised and marketable medicines in Germany covered by the agreement.
Show full summary

Open-house, non-exclusive pharmaceutical rebate agreement for Posaconazole (ATC J02AC04) with AOK Rheinland-Pfalz/Saarland in Germany. Eligible pharmaceutical companies may join under uniform, non-negotiable terms without a selection decision. The arrangement runs up to 31 May 2027, but contracts may be terminated or automatically replaced if exclusive rebate contracts are introduced. No estimated value or procurement documents were provided for analysis. The initial 30 April 2025 submission date has passed, but later monthly accession dates remain available until the final deadline.

Risks

No estimated value, expected demand, volumes, or other financial parameters are provided in the available notice.

The buyer may introduce exclusive rebate contracts during the term, causing the open-house contract to end automaticall...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only medicines authorised and marketable in Germany may be supplied under the agreement.
  • A medicine listed as marketable in the Lauer-Taxe is treated as meeting the marketability evidence requirement.

Administrative

  • If the medicine is not yet listed or the listing is not displayed, an AMIce public-database extract must be submitted with the contract documents.

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Posaconazole Pharmaceutical Rebate Agreement

Non-exclusive open-house rebate agreement for authorised and marketable Posaconazole medicines (ATC J02AC04). Kinderarzneimittel included in the relevant BfArM list under §35(5a) SGB V are excluded. Contracts use uniform conditions, cannot be individually negotiated, and may be concluded on the first day of a month during the participation period.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
235079-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy